Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study.

Otokozawa S, Ai M, Asztalos BF, White CC, Demissie-Banjaw S, Cupples LA, Nakajima K, Wilson PW, Schaefer EJ.

Atherosclerosis. 2010 Nov;213(1):251-5. doi: 10.1016/j.atherosclerosis.2010.02.041. Epub 2010 Mar 9.

PMID:
20863498
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.

Arsenault BJ, Rana JS, Stroes ES, Després JP, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT.

J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.

PMID:
20117361
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.

Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A; LIPID Study Investigators.

Eur Heart J. 2004 May;25(9):771-7.

PMID:
15120888
[PubMed - indexed for MEDLINE]
Free Article
4.

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW.

J Lipid Res. 1994 May;35(5):779-92.

PMID:
8071601
[PubMed - indexed for MEDLINE]
Free Article
5.

Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.

Carey VJ, Bishop L, Laranjo N, Harshfield BJ, Kwiat C, Sacks FM.

Am J Cardiol. 2010 Sep 15;106(6):757-63. doi: 10.1016/j.amjcard.2010.05.002. Epub 2010 Aug 1.

PMID:
20816113
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.

Bersot TP, Pépin GM, Mahley RW.

Am Heart J. 2003 Dec;146(6):1052-9.

PMID:
14660998
[PubMed - indexed for MEDLINE]
8.

Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.

Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ.

Clin Chem. 2010 Jun;56(6):967-76. doi: 10.1373/clinchem.2009.137489. Epub 2010 Apr 29.

PMID:
20431054
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.

Wang TD, Chen WJ, Chien KL, Seh-Yi Su SS, Hsu HC, Chen MF, Liau CS, Lee YT.

Am J Cardiol. 2001 Oct 1;88(7):737-43.

PMID:
11589839
[PubMed - indexed for MEDLINE]
10.

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG.

Curr Med Res Opin. 2002;18(4):220-8.

PMID:
12201623
[PubMed - indexed for MEDLINE]
11.

Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.

Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.

J Am Osteopath Assoc. 2002 Jul;102(7):377-84.

PMID:
12138952
[PubMed - indexed for MEDLINE]
Free Article
12.

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.

Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ.

Am J Cardiol. 2002 Oct 1;90(7):689-96.

PMID:
12356379
[PubMed - indexed for MEDLINE]
13.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195
[PubMed - indexed for MEDLINE]
Free Article
14.

Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.

Hu G, Cui Y, Jousilahti P, Sundvall J, Girman CJ, Antikainen R, Laatikainen T, Tuomilehto J.

Eur J Prev Cardiol. 2013 Feb;20(1):89-97. doi: 10.1177/1741826711428242. Epub 2011 Oct 24.

PMID:
22023802
[PubMed - indexed for MEDLINE]
15.

Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.

Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW; L-TAP 2 Investigators.

Am Heart J. 2009 Nov;158(5):860-6. doi: 10.1016/j.ahj.2009.08.009.

PMID:
19853709
[PubMed - indexed for MEDLINE]
16.

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J.

Circulation. 2001 Dec 18;104(25):3046-51.

PMID:
11748098
[PubMed - indexed for MEDLINE]
Free Article
17.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

PMID:
16316964
[PubMed - indexed for MEDLINE]
Free Article
18.

Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.

Zhang B, Bai H, Liu R, Kumagai K, Itabe H, Takano T, Saku K.

Metabolism. 2004 Apr;53(4):423-9.

PMID:
15045686
[PubMed - indexed for MEDLINE]
20.

Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.

Ogunro PS, Balogun WO, Fadero FF, Idogun ES, Oninla SO, Elemile PO, Eziyi AK.

West Afr J Med. 2009 Mar;28(2):87-91.

PMID:
19761169
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk